All In MedTech

Device Trial Radar · NCT05574361

Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)

A Prospective Multi-Center Continued Access Protocol for the Use of the LifePort® Liver Transporter (LLT) System With Vasosol® in Orthotopic Liver Transplants (PILOT™_CA: Perfusion to Improve Liver Outcomes in Transplantation_ Continued Access Arm)

Last checked: Nov 21, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

385

Actual

Start

Sep 19, 2022

Primary completion

Sep 23, 2025

Study completion Oct 23, 2026

Sponsor

Lead sponsor
Organ Recovery Systems, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 10, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To provide continued access for the LLT system to provide additional safety data in support of the PILOT pivotal efficacy and safety trial

Conditions

  • Liver Transplantation

Interventions

  • Hypothermic Machine PerfusionDevice

    Organ Recovery Systems LifePort® Liver Transporter (LLT) System and Vasosol® Machine Perfusion Solution

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Early Allograft Dysfunction (EAD)Time frame: 7 days

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Northwestern Memorial Hospital

    Chicago, Illinois

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.